Literature DB >> 20804376

Economic impact of Acinetobacter baumannii infection in the intensive care unit.

Bruce Y Lee1, Sarah M McGlone, Yohei Doi, Rachel R Bailey, Lee H Harrison.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20804376      PMCID： PMC3387729          DOI： 10.1086/656378

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  10 in total

1.  The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stay.

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  2002-02       Impact factor: 3.254

2.  Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.

Authors:  C M Weingarten; M J Rybak; B E Jahns; J G Stevenson; W J Brown; D P Levine
Journal:  Pharmacotherapy       Date:  1999-09       Impact factor: 4.705

3.  Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.

Authors:  J L García-Garmendia; C Ortiz-Leyba; J Garnacho-Montero; F J Jiménez-Jiménez; J Monterrubio-Villar; M Gili-Miner
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

4.  Attributable mortality of nosocomial Acinetobacter bacteremia.

Authors:  Mordechai Grupper; Hanna Sprecher; Tania Mashiach; Renato Finkelstein
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-07       Impact factor: 3.254

5.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

6.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

7.  Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury.

Authors:  Colin R Cooke; Jeremy M Kahn; Timothy R Watkins; Leonard D Hudson; Gordon D Rubenfeld
Journal:  Chest       Date:  2009-03-24       Impact factor: 9.410

8.  Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.

Authors:  A Abbo; Y Carmeli; S Navon-Venezia; Y Siegman-Igra; M J Schwaber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

9.  NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Authors:  Alicia I Hidron; Jonathan R Edwards; Jean Patel; Teresa C Horan; Dawn M Sievert; Daniel A Pollock; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

10.  Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

Authors:  Nan-Yao Lee; Hsin-Chun Lee; Nai-Ying Ko; Chia-Ming Chang; Hsin-I Shih; Chi-Jung Wu; Wen-Chien Ko
Journal:  Infect Control Hosp Epidemiol       Date:  2007-05-14       Impact factor: 3.254
  10 in total
  11 in total

1.  The economic burden of Clostridium difficile.

Authors:  S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

2.  Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

Authors:  S M Bartsch; J A McKinnell; L E Mueller; L G Miller; S K Gohil; S S Huang; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2016-09-15       Impact factor: 8.067

3.  Screening for Acinetobacter baumannii colonization by use of sponges.

Authors:  Yohei Doi; Ezenwa O Onuoha; Jennifer M Adams-Haduch; Diana L Pakstis; Traci L McGaha; Carly A Werner; Bridget N Parker; Maria M Brooks; Kathleen A Shutt; Anthony W Pasculle; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

4.  Economic value of Acinetobacter baumannii screening in the intensive care unit.

Authors:  B Y Lee; S M McGlone; Y Doi; R R Bailey; L H Harrison
Journal:  Clin Microbiol Infect       Date:  2011-04-04       Impact factor: 8.067

5.  The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Enterobacteriaceae Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia.

Authors:  Yasmeen Lashari; Maftuchah Rochmanti; Abdul Khairul Rizki Purba; Hari Basuki Notobroto; Rosantia Sarassari; Kuntaman Kuntaman
Journal:  Antibiotics (Basel)       Date:  2022-05-20

6.  Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.

Authors:  Timothy R Sampson; Xiang Liu; Max R Schroeder; Colleen S Kraft; Eileen M Burd; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.

Authors:  Teena Chopra; Dror Marchaim; Paul C Johnson; Reda A Awali; Hardik Doshi; Indu Chalana; Naomi Davis; Jing J Zhao; Jason M Pogue; Sapna Parmar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

8.  The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacter baumannii.

Authors:  Rima Moghnieh; Hani Tamim; Marwa Jadayel; Dania Abdallah; Rasha Al-Kassem; Hind Kadiri; Hani Hafez; Salam Al-Hassan; Lina Ajjour; Rawad Lakkis; Tamima Jisr; Nadia-Lara Samaha; Nicholas Haddad
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-14       Impact factor: 4.887

9.  Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.

Authors:  Tan N Doan; David C M Kong; Caroline Marshall; Carl M J Kirkpatrick; Emma S McBryde
Journal:  Virulence       Date:  2015-08-07       Impact factor: 5.882

10.  Clinical and economic outcomes of Acinetobacter vis a vis non-Acinetobacter infections in an Indian teaching hospital.

Authors:  Priyendu Asim; Nagappa Anantha Naik; Varma Muralidhar; K Eshwara Vandana; A Prabhu Varsha
Journal:  Perspect Clin Res       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.